[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37889]], camposKey:2213-2198 2018-01-01 Cocaine Allergy in Drug-Dependent Patients and Allergic People201207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12788]], camposKey:0301-0546 2017-01-01 Molecular diagnosis of allergy to Anisakis simplex and Gymnorhynchus gigas fish parasites463472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38040]], camposKey:1134-3230 2015-01-01 Description of disease type 1 diabetes mellitus associated autoimmune disease in a health area Descripción de las enfermedades autoinmunes acompañantes de la diabetes mellitus tipo 1 en un área sanitaria3035, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38032]], camposKey:0025-7753 2015-01-01 Description of the characteristics of the diabetic ketoacidosis debut in a sample of patients with type 1 diabetes mellitus Descripción de las características de la cetoacidosis diabética al inicio en una muestra de pacientes con diabetes mellitus tipo 1280281, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12780]], camposKey:0301-0546 2013-01-01 Clinical value of morphine, pholcodine and poppy seed IgE assays in drug-abusers and allergic people3744, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41031]], camposKey:1594-0667 2012-01-01 Risk of mortality and predisposing factors after osteoporotic hip fracture: A one-year follow-up study181187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12777]], camposKey:0301-0546 2011-01-01 Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users271279, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30386]], camposKey:0105-4538 2011-01-01 Clinical value of prick and IgE to morphine, pholcodine and opium seeds in the diagnosis of opiate allergy.258258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38105]], camposKey:1665-2681 2011-01-01 Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease5055, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38113]], camposKey:0250-6807 2011-01-01 Serum visfatin concentrations are related to dietary intake in obese patients265270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38124]], camposKey:1128-3602 2010-01-01 Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women759763, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13391]], camposKey:0212-1611 2010-01-01 Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients275279, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41034]], camposKey:0960-8923 2010-01-01 Influence of-55CT Polymorphism of UCP3 gene on surgical results of biliopancreatic diversion895899, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38128]], camposKey:1279-7707 2010-01-01 Prevalence of metabolic syndrome with international diabetes federation criteria and ATP III program in patients 65 years of age or older400404, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20589]], camposKey:0212-1611 2009-01-01 G1359A polimorfismo del receptor CB1 endocanabinoide (CNR1) en parámetros antropométricos y riesgo cardiovascular en pacientes con obesidad mórbida688692, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38147]], camposKey:0168-8227 2009-01-01 Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients174178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38139]], camposKey:1128-3602 2009-01-01 Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients413418, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38152]], camposKey:0250-6807 2008-01-01 Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome117121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38172]], camposKey:1128-3602 2008-01-01 Effects of lifestyle modification on adipocytokine levels in obese patients3339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38159]], camposKey:0212-1611 2008-01-01 Evaluation of two methods for correcting the impact factor using the investigation done at the "Del Río Hortega" University Hospital (1999-2004) as the data source Evaluación de dos métodos de corrección del factor de impacto utilizando la investigación del H. U. "Del Río Hortega" (1999-2004) como fuente de datos111118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40860]], camposKey:1178-6353 2008-01-01 Lipids and bone mineral density in patients with vascular disease2125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38179]], camposKey:0250-6807 2007-01-01 Lack of association of -55CT polymorphism of UCP3 gene with fat distribution in obese patients374378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38177]], camposKey:1094-6950 2007-01-01 OST Risk Index and Calcaneus Bone Densitometry in Osteoporosis Diagnosis404407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12764]], camposKey:1575-8435 2005-01-01 El tabaco como alérgeno en enfermedad bronquial obstructiva: Estudio preliminar1427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12765]], camposKey:0212-7199 2005-01-01 Estudio de la influencia del consumo de lácteos fermentados en una población de pacientes alérgicos5558, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30410]], camposKey:1081-1206 2005-01-01 Study of influence of dietary yogurt in an allergic population
[Estudio de la influencia del consumo de lácteos fermentados en una población de pacientes alérgicos]5558, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54504]], camposKey:1575-734X 2005-01-01 Tobacco as an allergen in bronchial obstructive disease: Preliminary report [El tabaco como alérgeno en enfermedad bronquial obstructiva. Estudio preliminar]1427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38217]], camposKey:0250-6807 2004-01-01 Effects of dietary intake and life style on bone density in patients with diabetes mellitus type 2141145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13017]], camposKey:1575-0922 2004-01-01 Papel del flúor en la osteoporosis426432][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30761]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145640209]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639908]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638830]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627622]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635977]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638780]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636276]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637333]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636859]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635913]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628060]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633341]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@730be71c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@36fa05b7, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@47497e40, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7fe567fc][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651765, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650ecd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650ecc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6513e7][][][][][][][][][][][][][][][]